CFDE Data Portal | Search GPAA1P1

	Label	Description
	GPAA1P1 Gene (Entity type)	ENSG00000240069 - glycosylphosphatidylinositol anchor attachment 1 pseudogene 1
	GSE176008 pyridoxine 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE229663 GSE229666 menin inhibition 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE178975 GSE178978 EGFR inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Pancreas 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdiposeTissue 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Nerve 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Lung 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SalivaryGland 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Lung 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx

GPAA1P1

ENSG00000240069 - glycosylphosphatidylinositol anchor attachment 1 pseudogene 1

GSE176008 pyridoxine 4 v 3 human dn

A Gene Set from LINCS

GSE229663 GSE229666 menin inhibition 3 v 2 human up

A Gene Set from LINCS

GSE178975 GSE178978 EGFR inhibition 1 v 0 human up

A Gene Set from LINCS

GTEx Pancreas 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx AdiposeTissue 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Nerve 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Lung 20-29 vs 60-69 Up

A Gene Set from GTEx

GTEx SalivaryGland 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Lung 20-29 vs 70-79 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.